Amsterdam-based Philips said Transcend Plus, the latest version of its Epiq CVx and Affiniti CVx systems, delivers major advancements in image quality and AI. That includes newly FDA-cleared 2D and 3D image quality enhancements and a growing suite of AI-enabled clinical applications.

Philips says it designed the offering to help cardiology teams work smarter, not harder. It aims to deliver fast, reproducible results with uncompromising image quality and decision-making support.

Transcend Plus visibly improves sharpness, contrast and detail in its imaging, the company said. The upgrades support superior visualization of cardiac anatomy and function to enable more diagnostic confidence in challenging, complex cases. This update also includes a new 2D Auto EF Advanced feature, expanding AI capabilities in assessing cardiac function